Pfizer's First Quarter Profits Blast Past 2022 Forecast
Video Credit: Wibbitz Top Stories - Duration: 01:31s - Published
Pfizer's First Quarter Profits Blast Past 2022 Forecast
Pfizer's First Quarter , Profits Blast Past, 2022 Forecast.
ABC reports that Pfizer's COVID-19 vaccine and treatment
sales helped propel the pharmaceuticals company
beyond Wall Street's first quarter expectations.
.
Pfizer's coronavirus vaccine
Comirnaty raked in over $13 billion
in sales for the first quarter.
.
Pfizer's coronavirus vaccine
Comirnaty raked in over $13 billion
in sales for the first quarter.
.
The vaccine has remained
Pfizer's top selling product
for almost the last year.
.
The drugmaker's pill treatment
Paxloid reportedly added an additional
$1.5 billion to the company's sales.
.
ABC reports that Pfizer's, profits grew 61% , in the first quarter.
.
On May 3, the company posted
a net income of $7.86 billion and first
quarter adjusted earnings of $1.62 per share.
.
The results easily exceeded
the $1.49 increase predicted
by industry analysts.
.
Compared to the same time last year,
the company's revenue skyrocketed 77% , to reach $25.66 billion.
.
According to ABC, the drugmaker
expects the company's total revenue in 2022
to reach between $98 billion and $102 billion.
.
Pfizer's COVID vaccine launched late
in 2020 and quickly became the company's
top selling product by the second quarter of 2021.
In December of 2021,
Pfizer's stock reached an
all-time high of $61.71 per share.
FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants.
NBC News reports that on June 30,
the Food and Drug Administration asked vaccine makers to modify upcoming booster shots to target subvariants of Omicron.
The Omicron subvariants the agency wishes to target are BA.4 and BA.5.
Officials have called on vaccine makers Pfizer-BioNTech and Moderna to produce bivalent vaccines, .
which are intended to target the original strain of COVID-19 as well as its subvariants.
As we move into the fall
and winter, it is critical that
we have safe and effective vaccine boosters that can
provide protection... , Dr. Peter Marks, FDA, via NBC News.
... against circulating
and emerging variants to prevent the most severe consequences of COVID-19. , Dr. Peter Marks, FDA, via NBC News.
As of the week ending June 25, Omicron subvariants BA.4 and BA.5 were responsible for 52% of all new cases of COVID-19.
Per the Centers for Disease Control and Prevention, BA.1, the first variant of
Omicron, caused 0% of new cases.
Pfizer and Moderna have thus far
altered vaccines to target the
original strain of COVID-19 and BA.1.
which increased the immune response to earlier iterations, though both have waned in their efficacy against BA.4 and BA.5
Credit: Wibbitz Top Stories Duration: 01:30Published
Elmo Gets Vaccinated , Against COVID.
Earlier this month, Moderna and Pfizer/BioNTech vaccines were given emergency use authorization for children as young as six months old.
The CDC also signed off on
the shots for kids under 5.
On June 28, 'Sesame Street' issued a public service announcement to spread the word.
Elmo's dad, Louie, addressed
getting his son vaccinated.
Elmo's dad, Louie, addressed
getting his son vaccinated.
Was it safe? Was it the right decision?’ I talked to our pediatrician so I could make the right choice. I learned that Elmo getting vaccinated is the best way to keep himself, our friends, neighbors and everyone else healthy and enjoying the things they love, Louie, Elmo's dad, via 'Sesame Street'.
According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to
"wait and see" before vaccinating their young kids.
According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to
"wait and see" before vaccinating their young kids.
Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, issued a statement about the PSA.
We hope that Louie and Elmo will inspire parents and caregivers across the country to speak with their healthcare providers and seek out information to learn about how the COVID-19 vaccines can keep young children and their families healthy, Jeanette Betancourt, senior vice president of U.S. social impact
at Sesame Workshop, via CNN.
The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated.
The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated
Credit: Wibbitz Top Stories Duration: 01:31Published
Pfizer Says Updated COVID-19 Shot , Effective Against Omicron.
NBC News reports Pfizer announced on
June 25 that its updated coronavirus vaccine
better targets the omicron variant.
Experts say while current vaccines offer ample protection against new variants, .
their effectiveness has waned
in the age of omicron.
The Food and Drug Administration has considered ordering altered vaccines, .
hoping a modified recipe could offer
more protection when coronavirus
surges again this fall and winter.
Pfizer says after studying over 1,200 adults who had received three vaccine doses.
officials say each of their vaccines
showed a substantial increase in omicron-resistant antibodies.
Based on these data,
we believe we have two
very strong omicron-
adapted candidates. , statement from Pfizer CEO Albert Bourla, via NBC News.
Pfizer's tweaked shot shows a 9 to 11-fold increase in omicron-fighting antibodies.
almost 1.5 times higher than
the company's initial dose
Credit: Wibbitz Top Stories Duration: 01:30Published
FDA Panel , Endorses
COVID Vaccines, for Children Under 5.
On June 15, an advisory panel to the United States
Food and Drug Administration voted to recommend
two COVID-19 vaccines for kids ages 5 and under.
Yahoo reports that both Pfizer/BioNTech
and Moderna were under review by the panel. .
The unanimous FDA panel vote
is the first step in what is predicted
to be a quick authorization process.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
Yahoo reports that parents now
have two options for how
to vaccinate their children.
Pfizer's vaccine for kids is delivered in three,
three-microgram doses, while Moderna's vaccine
is delivered in two shots of a 25-microgram dose.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
The committee’s support today
is imperative to providing a critical tool
for pediatricians, parents, and caregivers
who eagerly await an option
for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo.
Both companies are now awaiting approval from
the FDA and the CDC which will hold an advisory
committee meeting on the topic over the weekend.
Credit: Wibbitz Top Stories Duration: 01:30Published
Pfizer's COVID Vaccine
for Kids Under 5 , Moves Closer to FDA Approval .
Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.
Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.
The three-dose vaccine is for children between the ages of six months and five years.
Pfizer released a statement detailing the application.
Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News.
... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News.
... for children 6 months through
4 years of age (also referred to as
6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News.
Pfizer reported an 80 percent effectiveness rate in children in May.
The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application.
We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News.
... and while the FDA cannot predict how long its evaluation of the data and information
will take, , FDA Statement, via ABC News.
... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News.
According to a poll conducted by the
Kaiser Family Foundation in April of this year.
... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved.
27 percent of parents stated that they will "definitely not" vaccinate their children against COVID
Credit: Wibbitz Top Stories Duration: 01:31Published
In a slight relief to many, India recorded a major dip in Covid-19 cases after reporting more than 16,000 cases for the past few days. 13,086 fresh covid cases were added to the total tally of Covid-19 infections in the country on Tuesday. 19 covid related casualties were recorded on Monday. This was a major dip from 16,135 infections logged on Monday.
#CovidUpdate #Covid19Cases #Live
Pfizer’s COVID Booster Shot , for 5 to 11 Year Olds, Authorized by FDA.
NBC News reports on May 17, the Food
and Drug Administration (FDA)...
… announced it had authorized Pfizer-BioNTech's coronavirus
booster dose for 5 to 11 year olds.
The FDA says eligible recipients of a booster dose could receive the extra shot starting five months after their initial two-dose series.
Per NBC News, Pfizer's booster shot for
5 to 11 year olds is 10 micrograms ... .
... a third of the dosage given
to citizens 12 and older.
Following the FDA's ruling, it is now up
to the Centers for Disease Control and Prevention (CDC) to recommend how to implement boosters for the age group.
CDC data shows less than one third
of 5 to 11 year olds in the United States
have recieved the primary series of
a COVID-19 vaccine.
Experts say booster shots offer
better protection against the omicron
strain and its associated subvariants.
The CDC's Advisory Committee on Immunization Practices will reportedly discuss booster shots on May 19.
Dr. Rochelle Walensky, the Director of the CDC, should have her final recommendation following the committee's discussion
Credit: Wibbitz Top Stories Duration: 01:30Published
![FDA Calls for Fall COVID Boosters To Target Omicron Subvariants [Video]](https://video.newsserve.net/300/v/20220630/1337931914-FDA-Calls-for-Fall-COVID-Boosters-To-Target.jpg)
![Elmo Gets Vaccinated Against COVID [Video]](https://video.newsserve.net/300/v/20220628/1337835297-Elmo-Gets-Vaccinated-Against-COVID.jpg)
![Pfizer Says Updated COVID-19 Shot Effective Against Omicron [Video]](https://video.newsserve.net/300/v/20220627/1337781797-Pfizer-Says-Updated-COVID-19-Shot-Effective-Against.jpg)
![FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]](https://video.newsserve.net/300/v/20220616/1337268496-FDA-Panel-Endorses-COVID-Vaccines-for-Children-Under.jpg)
![Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval [Video]](https://video.newsserve.net/300/v/20220602/1336550862-Pfizer-COVID-Vaccine-for-Kids-Under.jpg)
![Covid-19 Update: India reports 13,086 fresh Covid cases in 24 hours | OneIndia News *News [Video]](https://video.newsserve.net/300/v/20220705/1338114340-Covid-19-Update-India-reports-13-086-fresh.jpg)
![Karlovy Vary film festival returns for its 56th edition after two years marred by COVID-19 [Video]](https://video.newsserve.net/300/v/20220705/1338083023-Karlovy-Vary-film-festival-returns-for-its-56th.jpg)
![Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA [Video]](https://video.newsserve.net/300/v/20220517/1335845739-Pfizer-COVID-Booster-Shot-for-to.jpg)
